Use of propranolol in infantile haemangioma among chinese children

Hong Kong Medical Journal

Volumn 16, Issue 5, 2010, Pages 341-346

  Chik, K K ^a   Luk, C K ^a   Chan, H B ^a   Tan, H Y ^a  

^a UNITED CHRISTIAN HOSPITAL   (Hong Kong)

Author keywords

Adrenergic beta antagonists; Facial neoplasms; Hemangioma; Infant; Propranolol

Indexed keywords

PREDNISOLONE; PROPRANOLOL; STEROID;

ARTICLE; CHILD; CHINESE; CLINICAL ARTICLE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FACE HEMANGIOMA; FEMALE; HEMANGIOMA; HUMAN; HYPOTENSION; INFANT; INFANTILE HEMANGIOMA; LOW DRUG DOSE; MALE; MONOTHERAPY; ONSET AGE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; TREATMENT DURATION; TUMOR RECURRENCE; WHEEZING;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FACE; FEMALE; FOLLOW-UP STUDIES; HEMANGIOMA; HONG KONG; HUMANS; HYPOTENSION; INFANT; MALE; NEOPLASM RECURRENCE, LOCAL; PROPRANOLOL; RETREATMENT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78649837810     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Frieden IJ, Eichenfield LF, Esterly NB, Geronemus R, Mallory SB. Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol 1997;37:631-637.
2. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992;326:1456-1463.
3. Murthy J. Vascular anomalies. Indian J Plast Surg 2005;38: 56-62.
4. Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland USA. Pediatr Dermatol 2005;22:383-406.
5. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649- 2651.
6. Sans V, Dumas de la Roque E, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009;124:e423-431.
7. Bennett ML, Fleischer AB Jr, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001;137:1208-1213.
8. Dinehart SM, Kincannon J, Geronemus R. Hemangiomas: evaluation and treatment. Dermatol Surg 2001;27:475-485.
9. Boon LM, MacDonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 1999;104:1616-1623.
10. Shorr N, Seiff SR. Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile hemangioma. Ophthalmic Surg 1986;17:229-231.
11. Sutula FC, Glover AT. Eyelid necrosis following intralesional corticosteroid injection for capillary hemangioma. Ophthalmic Surg 1987;18:103-105.
12. Sommers Smith SK, Smith DM. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim 2002;38:298-304.
13. Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008;122:360-367.
14. Metry DW. Epidemiology; pathogenesis; clinical features; and complications of infantile hemangiomas. UpToDate for Patients website: http://www.uptodate.com/patients/content/topic.do?topicKey=~aTXR1bK2I5I2CT. Accessed 28 Apr 2009.
15. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med 2008;359:2646; author reply 2846-7.